Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

DACH operators should feel positive about 2021

Despite one of the panellists at HBI's DACH-State of the Regions broadcast last week labelling 2020 "the wildest year in recent history in the healthcare sector", there are lots of reasons to feel positive about Europe's German-speaking countries as we look towards the new year.
November 26, 2020

Operators in Russia and ex-CIS hit hard by COVID

State financing has seen little growth in expenditure in Russia over the last couple of years, while former CIS countries are struggling to fund robust healthcare systems. Despite this, panellists at HBI's Russia and Former CIS - State of the Regions discussion last week found some reasons to be positive.
November 26, 2020

Emerging market lab roundup

HBI rounds up the latest news from the world's largest emerging market laboratories, including Grupo Fleury in Brazil striking a deal with a rival, and lab activity normalising in India.
November 19, 2020

Second wave of state financial support for private hospitals

Governments across Western Europe are re-instating financial support for private hospitals involved in the second wave pandemic response. Some are treating COVID patients for the first time as hospitalisations soar above first wave numbers, but support packages are heavily-adjusted from those in spring. We talk to operators in Italy, Portugal, Germany and Switzerland and provide an update on the UK and France.
November 19, 2020

Occupational healthcare “cuts cost of absenteeism by half”

The COVID-19 pandemic shifted the working patterns and environments of every type of workforce, resulting in big hits to free-for-service (FFS) business models and new opportunities in remote care. Panellists from Medicover, Medigold and Qualitas discussed this and how good occupational healthcare can reduce the costs of absenteeism by half, at last week's HBI Big Picture Seminar.
November 19, 2020

Diaverum to IPO in Stockholm as Saudi JV buyout boosts EBITA

Global renal care group Diaverum's upcoming Stockholm IPO has 'strong international and Swedish investor interest', CEO Dimitris Moulavasilis tells HBI, as the market reaches historic highs. We talk expansion and diversification plans and 2020 performance. 
November 18, 2020

COVID vaccine: Shot in the arm the markets needed?

Pfizer shares rocketed 15% on Monday with news of a vaccine that's more than 90% effective. But lab and telehealth shares plummeted upon the announcement while hospitals, care homes and outpatient groups recouped some of their YTD losses. HBI explores what a vaccine might mean across the five sub-sectors.
November 12, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us